Homoharringtonine, cytarabine and cyclopbosphamide in patients with acute myelogenous leukemia for induction chemotherapy

被引：0
|
作者：
Qiao, ZH [1 ]
Su, LP [1 ]
Jia, HF [1 ]
Liu, GJ [1 ]
Pei, YH [1 ]
机构：
[1] Shanxi Med Univ, Hosp 2, Dept Hematol, Taiyuan, Shanxi Province, Peoples R China
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4564
引用
收藏
页码：259B / 259B
页数：1
相关论文
共 50 条
  • [1] HOMOHARRINGTONINE IN COMBINATION WITH CYTARABINE FOR PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
    FELDMAN, E
    ARLIN, Z
    AHMED, T
    MITTELMAN, A
    PUCCIO, C
    CHUN, H
    COOK, P
    BASKIND, P
    LEUKEMIA, 1992, 6 (11) : 1189 - 1191
  • [2] Treatment with homoharringtonine and cytarabine in patients with high risk acute myelogenous leukemia (AML).
    Chang, Naibai
    Wei, Jianping
    Zhao, Shengming
    Liu, Hui
    Fan, Yun
    Li, Jiangtao
    Xu, Xiaodong
    Gu, Xichun
    BLOOD, 2006, 108 (11) : 218B - 218B
  • [3] HOMOHARRINGTONINE IS SAFE AND EFFECTIVE FOR PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
    FELDMAN, E
    ARLIN, Z
    AHMED, T
    MITTELMAN, A
    PUCCIO, C
    CHUN, H
    COOK, P
    BASKIND, P
    LEUKEMIA, 1992, 6 (11) : 1185 - 1188
  • [4] Homoharringtonine in childhood acute myelogenous leukemia
    Tang, JY
    Xue, HL
    Pan, C
    Chen, J
    Gu, LJ
    Chen, J
    Zhao, HJ
    Wang, YP
    BLOOD, 2002, 100 (11) : 260B - 260B
  • [5] Homoharringtonine based triple-drug regimen as induction chemotherapy for de novo acute myelogenous leukemia.
    Jin, Jie
    Qian, Wenbin
    Liu, Hui
    Jian, Daozi
    Mai, Wenyuan
    Tong, Hongyan
    Men, Haitao
    BLOOD, 2006, 108 (11) : 566A - 566A
  • [6] HIGH-DOSE CYTARABINE AND DAUNORUBICIN INDUCTION AND POSTREMISSION CHEMOTHERAPY FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS
    PHILLIPS, GL
    REECE, DE
    SHEPHERD, JD
    BARNETT, MJ
    BROWN, RA
    FREILAHR, DA
    KLINGEMANN, HG
    BOLWELL, BJ
    SPINELLI, JJ
    HERZIG, RH
    HERZIG, GP
    BLOOD, 1991, 77 (07) : 1429 - 1435
  • [7] Venetoclax Combined with Homoharringtonine and Cytarabine (HAV) As Induction Treatment in Elder or Intensive Chemotherapy (IC) Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia
    Liu, Kaiqi
    Suo, Xiaohui
    Bai, Guanchen
    Yan, Zhangsong
    Li, Yang
    Zhang, Bin
    He, Jinsong
    Wei, Shuning
    Li, Qiuling
    Hu, Bo
    Mi, Yingchang
    BLOOD, 2023, 142
  • [8] INFECTION OF ELDERLY PATIENTS RECEIVING HIGH-DOSE CYTARABINE-BASED CHEMOTHERAPY FOR INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML)
    NEMUNAITIS, J
    MEYER, W
    NEMUNAITIS, J
    TAYLOR, E
    RILEY, C
    COOPER, B
    LEUKEMIA RESEARCH, 1994, 18 (08) : 649 - 650
  • [9] CYTARABINE SYNDROME IN A PATIENT UNDERGOING CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA: A CASE REPORT
    Bayongasan, Rebekah
    CHEST, 2023, 164 (04) : 107A - 108A
  • [10] Intensive chemotherapy with idarubicin, cytarabine and G-CSF in elderly patients with acute myelogenous leukemia (AML)
    Chaibi, P
    Dombret, H
    Rousselot, P
    Gardin, C
    Glaisner, S
    Castaigne, S
    Degos, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 822 - 822
12345